San Francisco, CA, USA, March 28, 2018 – Trianni, Inc. (“TRIANNI”) and NovaRock Biotherapeutics, Ltd. (“NOVAROCK”) jointly announced today that […]
ENTHERA and TRIANNI Announce Licensing Agreement
San Francisco, CA, USA and Milano, Italy, March 22, 2018 – Trianni, Inc. (“TRIANNI”) and Enthera, S.r.l. (“ENTHERA”) jointly announced […]
TRIANNI sponsors The Werner Müller Award for Excellence in Immunology
San Francisco, CA, USA. and Berlin, Germany, December 6, 2017 –Trianni, Inc. (“TRIANNI”) announced that it will sponsor the Werner […]
Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform
San Francisco, CA, USA, October 18, 2017– Trianni, Inc. (“TRIANNI”). today announced that Juno Therapeutics (NASDAQ: JUNO) has entered into […]
TRIANNI Signs Agreement with Massachusetts General Hospital for Use of The Trianni Mouse™ in HIV Vaccine Research
San Francisco, CA, USA, June 1 2017 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into an agreement […]
TRIANNI and Olympic Protein Technologies Sign License Agreement for The Trianni Mouse™
San Francisco, CA and Seattle, WA, USA., May 24, 2017 –Trianni, Inc. (“TRIANNI”) and Olympic Protein Technologies (“Olympic”) jointly announced […]
Immunomic Therapeutics and TRIANNI Sign License Agreement for The Trianni Mouse™
Rockville, MD and San Francisco, CA, USA, May 18, 2017–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, and […]
TRIANNI Signs Agreement with Magenta Therapeutics for Use of The Trianni Mouse
San Francisco, CA, USA., March 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]
TRIANNI Signs Collaboration Agreement with Fred Hutchinson Cancer Research Center for use of The Trianni Mouse Platform
San Francisco, CA, USA, March 8, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has finalized a non-exclusive license agreement […]
GigaGen and Trianni Announce License Agreement for Discovery of Fully Human Immuno-Oncology Antibodies
Partnership leverages GigaGen’s industry-leading immune repertoire sequencing and expression technology and Trianni’s best-in-class human transgenic mouse platform. February 28, 2017– […]
Recent Comments